secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001493152-23-021113
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences regains compliance with Nasdaq equity requirement on June 13
--------------------------------------------------------------------------------

- Received formal notice from Nasdaq that it now meets the equity requirement under Listing Rule 5550(b)(1).
- The Nasdaq Hearings Panel matter concerning listing compliance has been closed.
- Ensysce common stock (ENSC) will continue trading on the Nasdaq Capital Market.
- Company cautioned that future compliance with all Nasdaq requirements is not guaranteed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/0001493152-23-021113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer